3^rd International conference on Digestive and Metabolic Diseases October 22-23, 2018 Berlin, Germany

Dr. Hohler completed the Boston University Seven Year Accelerated Medical Program in 1998. Dr. Hohler received a ROTC scholarship and upon completion of medical school entered the United States Army. She completed a neurology internship and residency at Madigan Army Medical Center in Tacoma, WA. Dr. Hohler served as Chief of the Neurology Clinic at Madigan Army Medical Center from 2002-2004 and Neurology Residency Program Director 2005-2006. Dr. Hohler completed a movement disorder fellowship at Boston University School of Medicine and joined the staff in 2007. Dr. Hohler serves as Director of the movement disorder section of the Braintree Rehabilitation Facility. Dr. Hohler participates in the management of Parkinson’s disease patients and adjusts patients with Deep Brain Stimulation. Her area of patient focus and research is advanced Parkinson’s disease and Parkinson Plus syndromes. Dr. Hohler is involved in autonomic research in Parkinson’s disease and MSA patients. Dr. Hohler is also actively involved in medical education research, and research on abuse and violence and its impact on neurology patients. Dr. Hohler is the Assistant Dean of Clinical Development and serves as the field specific advisor for medical students interested in neurology and is the advisor for the student interest group in neurology. Dr. Hohler teaching awards from American Academy of Neurology in 2003, 2005, and 2012 respectively. She has also received the Army Achievement medal, The Army Commendation Medal, and Two Meritorious Service Medals for excellence in clinical and teaching skills while serving on active Duty from 1998-2006. She was honorably discharged in 2006 having attained the rank of Major. She is the recipient of the prestigious Stanley Robbins BU teaching excellence award for 2012. Dr. Hohler is the current Co-chair of the Quality Safety Subcommittee of the American Academy of Neurology and the President of the Massachusetts Neurological Association. Anna DePold Hohler, M.D. Neurology BUMC

Neurology, Postural Tachycardia Syndrome

Robert D. Odze, MD, FRCP(C), Chief of Gastrointestinal Pathology Service at Brigham and Womens Hospital. He is an internationally recognized authority, lectures extensively, and works at one of the worlds leading institutions for pathology. He is an author of Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Dr. Odze holds his MD from McGill University, Montreal, where he was awarded the Pathology, Anatomy and Surgery Prize. He has served as associate editor of the American Journal of Gastroenterology and associate editor of IBD. He has published more than 300 peer-reviewed research articles, reviews, editorials, and book chapters.

Barretts esophagus, Esophageal cancer, Gastrointestinal pathology, Gastrointestinal polyps, Inflammatory bowel disease

David Van Thiel is a gastroenterologist in Berwyn, Illinois. He is affiliated with multiple hospitals in the area, including Rush Oak Park Hospital and Rush University Medical Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice for 39 years. Dr. Van Thiel accepts several types of health insurance, listed below. He is one of 21 doctors at Rush Oak Park Hospital and one of 25 at Rush University Medical Center who specialize in Gastroenterology. Dr. Van Thiel graduated from University of California at Los Angeles. Dr. David H Van Thiel, MD has obtained board certification from the member board for Internal Medicine and Hepatology.

David H Van Thiel, MD has expertise in 17 areas. This includes Cryoglobulinemia, Liver Diseases, Alcoholic Liver Cirrhosis plus others. Dr. David Van Thiel practices Internal Medicine, Hepatology, Gastroenterology near Chicago, IL.

Dr. Larry Good has been a practicing gastroenterologist since 1978. Dr. Good graduated Colgate University Magna Cum Laude in 1969 and received his M.D. with Alpha Omega Alpha status from the Medical University of South Carolina in Charleston, SC in 1973. Dr. Good served a medical residency from 1973-76 and was Chief Medical Resident in 1976. He was fellowship trained in gastroenterology from 1976-78. Dr. Good has served as the Director of Liver Diseases at Nassau County Medical Center and was for many years Chief, Division of Gastroenterology, Department of Medicine at South Nassau Communities Hospital. Dr. Good is an assistant clinical professor of medicine at SUNY Stony Brook. He has given hundreds of lectures in his field and has authored numerous papers and abstracts. Recently, Dr. Good presented the ACG Theater lecture at the American College of Gastroenterology annual meeting in Chicago, Illinois in October, 2014. Dr. Good was Chief Medical Officer at Ritter Pharmaceuticals in Los Angeles, California, where he expanded his research interest in the intestinal microbiome. Dr. Good’s current clinical research activities involve the microbiome, inflammatory bowel disease, irritable bowel syndrome and the application of orally administered gamma globulin to patients with acute and chronic gastro-intestinal disorders. Dr. Good founded Good Pharmaceutical Development Co., LLC, in 2014. He is their CEO and is developing a topical product for treating neuropathic pain. Dr. Good was recently appointed CEO of Compassionate Care Center of New York, a company founded to provide medical marijuana product safely and affordably to residents of New York State adhering to the evolving NYS regulations and producing a pharmaceutical grade treatment option for specific diagnosis designated use. Dr. Good was appointed as an editor of BMC Gastroenterology, a prestigious on line peer reviewed medical journal. He is a member of the Speakers Bureau for Entera Health, Abbvie and Cubist Pharmaceuticals. Dr. Good currently receives research grants from Entera Health and Medicus Biosciences. Dr. Good is the former C.E.O. of Compassionate Care Center of NY and has had a long interest in research application of the physiology of natural molecules to multiple disease states. Currently, Dr. Good is the C.E.O. of New Century Health Alliance, L.L.C., a Continuing Medical Education Company certified to provide 6.25 AMA PRA credits for education in the area of medical marijuana treatment. In May, 2016, Dr. Good was named to the Steering Committee for Medical Marijuana Research and Education Division, Department of Integrated Medicine at Thomas Jefferson Medical University in Philadelphia. He has just completed a manuscript soon to be published on the treatment of Crohn’s Disease and Ulcerative Colitis with medical marijuana pharmaceuticals.

Gastroenterology, Crohn’s Disease and Ulcerative Colitis

Chait completed his MD degree at the age of 25 from the University of California School of Medicine at San Francisco. Maxwell is a Fellow of several prestigious organizations, including the American College of Physicians, American College of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He is a practicing gastroenterologist on the faculty of the Columbia University College of Physicians and Surgeons. Dr. Maxwell has authored more than 37 publications in reputed journals and serves on the editorial board of the World Journal of Gastrointestinal Endoscopy.

Gastroenterology and Gastrointestinal endoscopy.